Regulation of type 1 inositol 1,4,5-triphosphate receptor by dopamine receptors in cocaine-induced place conditioning

Synapse

Volumn 66, Issue 2, 2012, Pages 180-186

  Kurokawa, Kazuhiro ^a   Mizuno, Koji ^a   Shibasaki, Masahiro ^a,b   Ohkuma, Seitaro ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b HOSHI UNIVERSITY   (Japan)

Author keywords

2 APB; Cocaine; Conditioned place preference; Dopamine receptors; Type 1 inositol 1,4,5 triphosohate receptors; Xestospongin C

Indexed keywords

2 AMINOPHENOXYETHANE BORATE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CALCIUM CHANNEL BLOCKING AGENT; COCAINE; DOPAMINE RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR 1; SULPIRIDE; UNCLASSIFIED DRUG; XESTOSPONGIN C;

ANIMAL EXPERIMENT; ARTICLE; COCAINE DEPENDENCE; CONDITIONING; FRONTAL CORTEX; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL;

ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MALE; MICE; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SIGNAL TRANSDUCTION;

EID: 83055184093     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20997     Document Type: Article

References (18)

1. Ahn KC, Bernier BE, Harnett MT, Morikawa H. 2010. IP3 receptor sensitization during in vivo amphetamine experience enhances NMDA receptor plasticity in dopamine neurons of the ventral tegmental area. J Neurosci 30: 6689-6699.
2. Baker DA, Fuchs RA, Specio SE, Khroyan TV, Neisewander JL. 1998. Effects of intraaccumbens administration of SCH-23390 on cocaine-induced locomotion and conditioned place preference. Synapse 30: 181-193.
3. Berridge MJ, Lipp P, Bootman MD. 2000. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1: 11-21.
4. Blondel O, Takeda J, Janssen H, Seino S, Bell GI. 1993. Sequence and functional characterization of a third inositol trisphosphate receptor subtype, IP3R-3, expressed in pancreatic islets, kidney, gastrointestinal tract, and other tissues. J Biol Chem 268: 11356-11363.
5. Grayson TH, Haddock RE, Murray TP, Wojcikiewicz RJ, Hill CE. 2004. Inositol 1, 4, 5-trisphosphate receptor subtypes are differentially distributed between smooth muscle and endothelial layers of rat arteries. Cell Calcium 36: 447-458.
6. Inoue Y, Yao L, Hopf FW, Fan P, Jiang Z, Bonci A, Diamond I. 2007. Nicotine and ethanol activate protein kinase A synergistically via G(i) betagamma subunits in nucleus accumbens/ventral tegmental cocultures: The role of dopamine D(1)/D(2) and adenosine A(2A) receptors. J Pharmacol Exp Ther 322: 23-29.
7. Kurokawa K, Mizuno K, Shibasaki M, Ohkuma S. 2010. Regulation of ryanodine receptors by dopamine D(1) receptors during methamphetamine-induced place conditioning. J Neurochem 115: 1206-1214.
8. Kurokawa K, Shibasaki M, Mizuno K, Ohkuma S. 2011. Gabapentin blocks methamphetamine-induced sensitization and conditioned place preference via inhibition of alpha(2)/delta-1 subunits of the voltage-gated calcium channels. Neuroscience 176: 328-335.
9. + signaling. Curr Opin Neurobiol 7: 339-345.
10. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. 1998. Dopamine receptors: From structure to function. Physiol Rev 78: 189-225.
11. Mizoguchi H, Yamada K, Mizuno M, Mizuno T, Nitta A, Noda Y, Nabeshima T. 2004. Regulations of methamphetamine reward by extracellular signal-regulated kinase 1/2/ets-like gene-1 signaling pathway via the activation of dopamine receptors. Mol Pharmacol 65: 1293-1301.
12. Narita M, Takei D, Shiokawa M, Tsurukawa Y, Matsushima Y, Nakamura A, Takagi S, Asato M, Ikegami D, Amano T, Niikura K, Hashimoto K, Kuzumaki N, Suzuki T. 2008. Suppression of dopamine-related side effects of morphine by aripiprazole, a dopamine system stabilizer. Eur J Pharmacol 600: 105-109.
13. Nazarian A, Russo SJ, Festa ED, Kraish M, Quinones-Jenab V. 2004. The role of D1 and D2 receptors in the cocaine conditioned place preference of male and female rats. Brain Res Bull 63: 295-299.
14. Nestler EJ. 2005. Is there a common molecular pathway for addiction? Nat Neurosci 8: 1445-1449.
15. Sershen H, Hashim A, Lajtha A. 2010. Differences between nicotine and cocaine-induced conditioned place preferences. Brain Res Bull 81: 120-124.
16. Taylor CW, Rahman T, Tovey SC, Dedos SG, Taylor EJ, Velamakanni S. 2009. IP3 receptors: Some lessons from DT40 cells. Immunol Rev 231: 23-44.
17. +-release. Invest Ophthalmol Vis Sci 52: 3874-3879.
18. Tzschentke TM. 2007. Measuring reward with the conditioned place preference (CPP) paradigm: Update of the last decade. Addict Biol 12: 227-462.